作者: Rebeccah A. McKibben , Mahmoud Al Rifai , Lena M. Mathews , Erin D. Michos
DOI: 10.1007/S12170-015-0480-3
关键词:
摘要: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality among women. Despite improvements in prevention efforts, there remain gaps awareness women, as well age racial disparities ASCVD outcomes for Disparity also exists impact traditional risk factors confer on between women men, with smoking diabetes both resulting stronger relative risks compared to men. Additionally are that unique (such pregnancy-related factors) or disproportionately affect auto-immune disease) where preventive efforts should be targeted. Risk assessment management must sex-specific effectively reduce improve Evidence supports use statin therapy primary at higher risk. However, some pause given before prescribing aspirin without known ASCVD, most evidence supporting ≥65 years not increased bleeding. This review article will summarize (1) non-traditional assessments (2) lifestyle pharmacologic therapies